Clostridium difficile Colitis Prevention and Treatment.
Study Design
- Çalışma Türü
- Review
- Popülasyon
- None
- Müdahale
- Clostridium difficile Colitis Prevention and Treatment. None
- Karşılaştırıcı
- None
- Birincil Sonuç
- Diarrhea outcomes
- Etki Yönü
- Mixed
- Yanlılık Riski
- Unclear
Abstract
Clostridium difficile (C. diff) is the most common causative agent of antibiotic-associated diarrhea and colitis. This spore-forming, obligate anaerobic, gram-positive bacillus is becoming responsible for an increasing number of infections worldwide, both in community and in hospital settings, whose severity can vary widely from an asymptomatic infection to a lethal disease. While discontinuation of antimicrobial agents and antibiotic treatment of the infection remain the cornerstone of therapy, the use of probiotics, especially Saccharomyces boulardii, and more recently of fecal microbiota transplantation have become valid forms of prevention and/or therapy and are here critically examined.
Kısaca
Probiotics, especially Saccharomyces boulardii, and more recently of fecal microbiota transplantation have become valid forms of prevention and/or therapy and are here critically examined.
Used In Evidence Reviews
Similar Papers
The American journal of gastroenterology · 2006
Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease.
The American journal of clinical nutrition · 2001
Protection from gastrointestinal diseases with the use of probiotics.
Advances in biochemical engineering/biotechnology · 2008
Probiotics, prebiotics, and synbiotics.
World journal of gastroenterology · 2010
Systematic review and meta-analysis of Saccharomyces boulardii in adult patients.
Frontiers in medicine · 2018
Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis.
Journal of clinical gastroenterology · 2011